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LNTBODUCTION
Valuable contributions for the understanding of host-agent interaction in experimental tuberculosis have been made by detailed histologic and bacteriologic studies (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Important as the findings of such studies are, it would nevertheless seem that their significance must eventually be evaluated in terms of the final outcome of the infection, that is, in terms of tuberculous disease and death. Justification for this view, especially for the studies of the mechanisms of immunity, may be found in the enormous literature on experimental tuberculosis, all of which indicates that the final outcome of a virulent tuberculous infection in naturally susceptible laboratory animals, whether immunized or not, is disease and eventual death from tuberculosis (12) (13) (14) (15) (16) . In these terms, immunization prolongs life, and thus, in the end, its effect apparently is to reduce the speed with which the virulent infection progresses.
Immunization, however, is not the only factor that can influence the pro- > The author gratefully acknowledges the skillful work of the entire staff at Tuberculosis Program's research laboratories in Chamblee, Georgia, which made it possible to earry out an experiment of the kind which forms the basis of the present paper.
gression of an experimental infection. Simplest of all, perhaps, is the number of bacilli in the infecting dose. By reducing the number, progression of the infection is slowed and survival time is prolonged. The fact that survival time can be prolonged, on the one hand, by immunization without changing the size of the infecting dose, and on the other hand by changing the number of bacilli contained in the infecting dose without immunization, suggests that it might be possible to equate, in quantitative terms, the effect of immunization with a certain change in number of virulent bacilli contained in the infective dose. This possibility is explored in the present paper.
Three types of observations will be discussed: time of spontaneous death, extent of tuberculous lesions at time of death, and changes in body weight after infection. Although none of these observations furnishes the kind of information that is often considered essential for describing the mechanism of the infective process, all of them represent objective, clear cut measures of the major consequences of tuberculous infection.
MATERIAL AND METHODS
The experiment, identified as study XI, which forms the basis for the present paper, is one of a continuing series being conducted at the Tuberculosis Program's research laboratory in Chamblee, Georgia (17) . An earlier publi-cation (18) gives a full account of the material and laboratory procedures of the experiment and only a brief summary will be given here.
Of a total of 830 young Hartley strain guinea pigs, 471 were injected intradermally (vaccinated) with standard strength Danish BCG. The remainder, a comparable group of 359 animals, were given an intradennal placebo injection of normal saline. Thirteen weeks later, 4 comparable subgroups of both the vaccinated and unvaccinated were either injected intraperitoneally (challenged) with one of 3 serially diluted suspensions of virulent tubercle bacilli (H37Rv), or injected with normal saline to serve as control groups. Table 1 gives the number of animals included in each subgroup or regimen and shows that the 3 suspensions of H37Rv represent 100-fold dilutions which range from 2,850,000 to 285 viable bacillary units per challenge dose. During the study period, the animals were weighed and tuberculin tested (25 TU of PPD-S) at intervals. Those that died were examined for gross evidence of tuberculosis and date of death was recorded. A few animals were sacrificed at the end of the study period (85 weeks) and findings at autopsy were recorded as for those that had died spontaneously.
RESULTS

Effect of vaccination in preventing infection with virulent tubercle bacilli.
When groups of unvaccinated guinea pigs are inoculated with serially diluted suspensions of virulent tubercle bacilli, the percentage of animals that become infected increases as the number of bacilli in the challenge dose is increased (19, 20) . It is difficult to interpret this finding in any way other than that the number of bacilli necessary to initiate an infection, the minimal infective dose, varies considerably among individual animals. The minimal infective dose cannot, in other words, be thought of as a certain number of bacilli above which all animals will become infected, and below which none will become infected. Rather, we must visualize a distribution of minimal infective doses which reflects marked differences in the capacity of individual animals to destroy all bacilli in the challenge dose before any of them can initiate an infection.
To determine whether vaccination changes the distribution of minimal infective doses by rendering the animals better able to destroy all bacilli of a larger challenge dose, it is necessary to classify each animal as to whether or not it became infected by the challenge inoculation. It is probably desirable also to use a challenge dose containing an average number of bacilli below the minimal infective dose for some of the unvaceinated animals and above that dose for others.
Classification of individual fl.TiiTnfl.i3 as "infected" or "not infected" by a challenge, as shown in earlier papers (19, 20) , may be based on findings at autopsy and by results of periodic tuberculin tests.
As can be seen in table 2, tuberculous lesions were found at autopsy in 301 (97.7 per cent) of 308 unvaceinated challenged flniTnalg, and in 351 (92.9 per cent) of 378 vaccinated challenged H. niTnfl. lH. Although naturally acquired tuberculous infection cannot be excluded as a cause of the tuberculous lesions in these animals, such infections occur so rarely that to regard all challenged animals with tuberculous lesions at autopsy as in fact infected by the challenge inoculation would probably involve a negligible error.
On the other hand, the 7 unvaceinated challenged animals and the 27 vaccinated challenged nniTTifl.13 with no tuberculous lesions at autopsy (or with incomplete autopsy examination) may or may not have been infected by the challenge; they may have died from extraneous causes before tuberculous lesions had time to develop. These animals are classified on the basis of results of the periodic tuberculin tests, shown in table 3 for the unvaceinated  and in table 4 for the vaccinated animals. 
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For unvaccinated animals, interpretation of the results is reasonably simple. Development of tuberculin, sensitivity soon after challenge (within 12 weeks), as established by findings in earlier experiments (20, 21) , can be regarded as sufficient evidence that the challenge inoculation initiated a tuberculous infection. Challenged animals that remained tuberculin negative for at least 12 weeks can be regarded as not infected by the challenge. According to these criteria, 3 of the 7 unvaccinated animaia with no tuberculous lesions at death, listed as numbers 1-3 in table 3, are classified as infected; they all reacted to tuberculin at the first test after challenge. The remaining 4 animals can safely be classified as not infected by the challenge.
For vaccinated animals, as reported in a previous paper (18) , use of tuberculin test results as a guide to whether or not a challenge initiated an infection is seriously complicated by the fact that vaccination sensitizes guinea pigs to tuberculin. Although no fixed rules or criteria could be established, it was observed that an indication of superinfection with virulent bacilli could be based on changes in the size of reactions after challenge. In general, the reactions increased or remained relatively unchanged in animals that showed tuberculous lesions at autopsy. The size of reactions in vaccinated but unchallenged animals (with, of course, no lesions at autopsy) decreased slowly with time. On this basis, the sharp increase in size of reactions in animals listed as numbers 2 to 4 in table 4, can be taken as definitely indicating that the challenge initiated a tuberculous infection. Results in animals listed as numbers 5 to 17 indicate that degree of tuberculin sensitivity after challenge was maintained and in most cases increased, a trend which suggests the presence of a tuberculous infection. Results listed in table 4 for the last 5 animAlâ re not likely to be observed in the presence of a tuberculous infection, and these animals are therefore classified as not infected.
Animals listed as numbers 18 to 22, all females and challenged with the smallest dose (2.5), remain to be classified. It is quite uncertain what the results of tests for these 5 animals signify in terms of presence or absence of a virulent infection. Reactions in general are small, but quite stable, and one cannot with confidence exclude the presence of a virulent infection. In view of this uncertainty it is perhaps most satisfactory to give two estimates of percentage infected, one based on the assumption that all of the 5 were infected, another on the assumption that none was infected.
Classification of all animals, vaccinated as well as unvaccinated, is summarized in table 5. Among the unvaccinated, the only animals considered not infected, 1 male and 3 females, were in the smallest challenge dose regimen. Among the vaccinated, all of the males, regardless of size of the challenge, became infected. As table 5 also indicates, vaccination did nothing to reduce the percentage of infected among females given the largest and middle size challenge dose. The only indication from the present study, that vaccination might increase the minimal infective dose, and thereby influence the incidence of infection, depends on the interpretation of results for females given the smallest challenge dose. Among the 50 unvaccinated females in regimen 2.5, only 3 were classified as not infected, that is, 94 per cent became infected. Among the 61 vaccinated females in regimen 2.5, no less than 83.6 per cent became infected. Because of the uncertainty of this estimate (83.6), it maybe better to accept the alternate estimate of 91.8, and to conclude that minimal infective dose cannot be appreciably larger in a vaccinated animal than it would have been had the animal not been vaccinated.
Effect of vaccination on survival. Survival times of all animals in the present experiment are listed in table 6.
Of 144 unchallenged control animals, both unvaccinated and vaccinated, 70 died between the time of challenge and the end of the observation period 72 weeks later. Mortality over the whole period was somewhat higher among males (57.5 per cent) than females (39.4 per cent), and somewhat higher among the unvaccinated(56.9 per cent) than the vaccinated (44.1 per cent). These deaths among unchallenged controls are indicative of extraneous forces of mortality which will affect the survival of challenged animals in addition to the force of mortality imposed by the experimental infection. Some investigators (22) (23) (24) regard challenged animals with no or only slight tuberculous lesions at death as having died of extraneous causes and exclude them in the analysis of results. However, as pointed out in the next section, to do so would distort the results of the pres- ent experiment. Since no appropriate method is available for correcting for extraneous deaths (25) , it is believed that the least distortion would be obtained if all challenged animals classified as infected were considered as having died as a result of the tuberculous infection, and all challenged animals classified as not infected as surviving indefinitely in terms of tuberculosis as a cause of death.
The survival curves shown in figure 1 are constructed according to this concept: all animals in a regimen are included but only deaths among animals classified as infected are counted in calculating the percentage alive at the end of each consecutive week after challenge. It can be seen from this figure that the results of the present experiment confirm what is generally found, that vaccinated survive longer than unvaccinated animals inoculated with the same challenge dose, and that the smaller the challenge dose, the longer the survival time. It can also be seen from this figure that the survival curve for vaccinated animals challenged with the largest dose (6.5) is almost superimposed on the survival curve of unvaccinated animals challenged with the medium dose (4.5). Thus the effect of vaccination on survival can apparently be negated by increasing the number of bacilli in the challenge dose.
To examine how much the survival time of vaccinated animals is prolonged for different sizes of challenge doses, another method (19) is used to construct survival curves. The method involves dividing each regimen into subgroups, called survival groups, according to length of survival of the individual animals, and calculating the mean survival time for each of these groups. The subdivision of the various regimens and mean survival times for all survival groups are shown in table 7. The means are plotted on a logarithmic time scale and the resulting survival curves are compared separately in figure 2 for males and females of each challenge regimen. The curves for each pair of unvaceinated and vaccinated groups are almost parallel, which, with a logarithmic time scale, means that increase in survival time of vaccinated over unvaceinated of the same challenge regimen is proportionally the same whether comparison is made between animals that die early or late. Furthermore, the distance on the log-time scale between the pair of curves for each sex is almost the same in all 3 challenge regimens. This is illustrated in figure  3 , where the 3 pairs of survival curves for each sex were displaced so that the curves for the unvaceinated groups would be superimposed, as nearly as possible. It is apparent that corresponding curves for the vaccinated groups then also came close to being superimposed.
The result of this simple graphical comparison is taken to mean that survival of vaccinated animals is increased proportionately whether the challenge dose contains millions or only a few hundred viable bacillary units. The increase, as can be seen in figure 3 , is somewhat greater for females than males and can be estimated to be about 2.7 fold for females and 2.1 for males. The effect of vaccination in delaying progression of a virulent infection is apparently relatively the same for a wide range of sizes of challenge doses and slightly greater for females than males.
Effect of vaccination on extent of tuberculous lesions at time of death.
The bodies of most of the animals that died or were sacrificed were carefully examined (a few were too decomposed for satisfactory examination). The same person made all of the autopsies throughout the study and at the time of examination was not allowed to have any information on the regimen to which any animal had belonged. Total body weight and weights of the lungs, liver, spleen, omentum and gonads were recorded; gross abnormalities were noted; and all lesions attributed to tuberculosis were graded on a rough quantitative scale from 1 (for slight or minor involvement) through 5 (for extensive involvement or large lesions). The results of this grading of lesions -are to be reported in this section.
Twelve animals were excluded: 9 •classified as not infected; 1 that was unclassifiable; and 2 classified as infected that did not die spontaneously and were sacrificed at the end of the study period. This left 674 challenged animals for the analysis, although autopsy information was incomplete for 8 of these.
Grade of tuberculous lesions at death is given for each animal in table 6 and summarized by distributions and mean grades for each challenge regimen in table 8 . Although most of the animals were classified as having extensive tuberculous lesions at death, differences among regimens are apparent. The extent of lesions apparently decreased with increasing size of the challenge in unvaccinated animals, while the reverse was true in the vaccinated. In particular, lesions were less extensive in the unvaccinated challenged with the largest dose (6.5) and in the vaccinated challenged with the smallest dose (2.5), the two regimens that showed the greatest difference in time of survival (figure 1) .
Deaths from extraneous causes could perhaps account for the smaller lesions observed in vaccinated animals challenged with the smallest dose (2.5). These animals would be expected to survive the longest and would therefore have the greatest chance of dying from In view of these findings, an attempt to correct for extraneous causes of death by excluding from the analysis animals with only small tuberculous lesions, would not have been justified, and would, no doubt, have led to erroneous conclusions. The findings indicate also that the quantitative scale used for grading tuberculous lesions was sensitive enough to disclose differences in gross pathology related to progression of infection as reflected by differences in survival times. Thus, if there are differences attributable to vaccination they could be expected to appear by a comparison between unvaccinated and vaccinated animals that survived equally long (i.e., unvaccinated animals challenged with the medium dose and vaccinated animals challenged with the largest dose). However, as can be seen from figure 4, distributions of grades of tuberculous lesions in these two regimens are almost the same. The slight differences between them might be related to the small differences in survival time observed in these two regimens, a possibility supported by the material shown in figure 5 . In this graph, mean grade of tuberculous lesions for each survival group of the two regimens is plotted according to mean survival time of the respective survival groups (table 7) . Within both regimens, less extensive lesions are observed in animals with the shortest and longest survival times, but grade of tuberculous lesions is nearly the same in survival groups with about the same mean survival time. A virulent tuberculous infection apparently produces lesions which in extent are no different at time of death in unvaccinated and vaccinated animals that survive equally long.
Grade of tuberculous lesions at death in wwacdnated and vaccinated challenged guinea pigs classified as infected
Effects of vaccination on changes in body weight after challenge. Although weight loss or failure to gain in weight is not specific for tuberculosis, it nevertheless seems reasonable to attribute to the tuberculous infection the failure of challenged animals to maintain the same body weights as unchallenged controls. Moreover, the weight loss, and the way it occurs, must be closely correlated with the extent to which the tuberculous infection affects the general health of the animals. Changes in body weights after challenge are accordingly used to evaluate what might be considered the "clinical course" of tuberculosis in individual animals.
The animals were weighed each week through the first 8 weeks after challenge, biweekly during the next 40 weeks, and monthly for the last 6 months of the study period. The average weight at time of challenge was 879 grains for all males and 764 grams for all females. The unchallenged male controls gained about 170 grams, females 140 grains, on the average, to reach close to full growth about 16 weeks after challenge. Thus, the weight a challenged animal fails to gain must be estimated in terms of the weight it would have attained had it not been challenged: the "estimated normal weight." Analysis of body weight of unchallenged control animals showed that the weight an individual animal gained after time of challenge tended to be proportional to its weight at the time of challenge. Estimated normal weight at a specified time after challenge could therefore be obtained for individual animals by multiplying its actual weight at time of challenge by a factor obtained as the ratio of the average weight of all unchallenged controls at the time specified to the average weight of these animals at time of challenge. The difference in grams between estimated normal weight and actual weight at a particular time would then give an estimate of the weight an animal had lost up to that time. However, it was found more convenient to deal with relative weight losses and express actual weight as a percentage of estimated normal weight which, in the following, is called "relative weight."
For unchallenged controls the relative weight should average 100 per cent, but deviations from 100 would, of course, be observed for individual fl-ninnOn, An indication of the magnitude of the deviations is given in figure 6 by the relative weights of 7 male and 7 female unchallenged controls that survived the total?, study period. The deviations after maturity were approximately within the range of ± 15 per cent, but the relative weights of individuals were fairly stable, being consistently above or below 100. Deviations from a stable relative weight rather than deviations from 100 would therefore seem the important consideration in the comparison of weight curves. The slope of the curve is also more important than the relative weights as such.
An analysis in conventional statistical terms of the relative weights of the challenged animals will not be attempted FIQUBE 6 . Relative body weights of 7 male and 7 female unchallenged control guinea pigs that were alive when the study was discontinued 72 weeks after challenge.
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here. Instead, weight curves for selected animals of the different regimens are shown in figures 7, 8 and 9 to illustrate the principal findings.
One principal finding is illustrated in figure 7 , which shows weight curves for one unvaccinated and one vaccinated animal of each sex from each of the 3 challenge regimens.
Animals selected for illustration are among those that .
•survived about 22 weeks, which was the lime that had to be chosen in order to include in the comparison animals from every challenge regimen. The weight curves are very similar, suggesting that body weights of tuberculous animals that survive about the same length of time are affected equally, regardless of the size of challenge dose and previous vaccination. Figure 8 is another illustration. "Weight curves are shown for selected animals of the unvaccinated group challenged with the medium dose 4.5 and the vaccinated group challenged with the largest dose 6.5, the two regimens with almost identical survival curves. Three pairs of animals of each sex were chosen to show weight curves for animals in the two regimens that died early, for animals with about average survival times, and for animals that died late. 
WEEKS AFTER CHALLENGE
FiGtrra 8. Belative body weights of selected male and female guinea pigs from the unvaccinated groups challenged with an estimated 28,500 viable bacillary units (regimen 4.6) and selected male and female guinea pigs with comparable survival times from the vaccinated groups challenged with an estimated 2,860,000 viable baeillary units, the two regimens with almost identical survival curves.
"clinical course" of tuberculosis in vaccinated animals is the same as in unvaccinated am'main, providing they survived equally long.
Another principal finding is illustrated in figure 9 . Shown are weight curves for animals of the various challenge regimens selected to cover the full range of survival times of the study population. For animals with the shortest survival times, body weight is apparently affected immediately after infection and as indicated by the steep slope of the weight curves, loss of weight occurs rapidly. For animals with the longer survival times body weight remains about normal for varying lengths of time after infection. Also, the period of time during which weight remains unaffected is apparently closely related to survival. When weight starts to decline, however, the rate of loss is apparently about the same. It would seem from this illustration that the clinical course of tuberculosis, except in animals in which infection progressed very rapidly, differs mainly by the length of time it takes the infection to progress to the point of affecting the general health of the animal. Since the period during which body weight remains unaffected (the clinically latent period) is closely related to length of survival, the period will be inversely proportional to the size of the infecting dose, and from the analysis of the effect of vaccination on survival it will be apparent that vaccination will delay the emergence of "clinical tuberculosis" progressively longer for a decreasing number of virulent bacilli in the infecting dose. An infection initiated with a small number of virulent bacilli in vaccinated animals apparently progresses so slowly that it must be of almost no consequence for the general health of the animal for as long as 40 weeks after infection, a period which represents a considerable part of the animals' normal life span. 
DISCUSSION
No definitive evidence was found in the present study that the minimal infective dose is appreciably larger in a vaccinated animal than it would have been without vaccination. Thus, the chances of becoming infected with virulent tubercle bacilli will apparently, everything else being equal, not be reduced to any appreciable extent by vaccination. Although the smallest challenge dose may have contained a larger number of viable bacilli (estimated to average 285) than would be ideal for studying the problem, it was small enough so that a few unvaccinated animals did not become infected. Vaccination before challenge, however, did not increase significantly the percentage that did not become infected. The sole effect of vaccination, apparently, is to reduce the speed with which infection progresses, and to delay the time at which death from tuberculosis eventually occurs.
By inoculating vaccinated fl.nimH.1s with a larger number of virulent bacilli than given a comparable group of unvaccinated animals, loss of body weight after infection, extent of gross tuberculous pathology at time of death, and length of life itself can be equalized. Thus it appears that the effect of vaccination on the progression of a virulent infection can be equated to a difference in the number of bacilli in the infecting dose.
Estimates of how much the dose would need to be increased to negate the effect of vaccination may be obtained from the survival curves shown in figure 1. Because the curve for vaccinated animals challenged with the largest dose was practically superimposed on the curve for the unvaccinated animals challenged with the medium dose, and, because these two doses were prepared to differ by 100-fold, we may estimate that vaccination can be equated to a 100-fold increase in number of bacilli in the infecting dose. Survival curves for the vaccinated animals challenged with the middle size dose and unvaccinated animals challenged with the smallest dose are however not superimposed; in- stead, the vaccinated animals survived longer than the unvaccinated. Because these two doses were also prepared to differ by 100-fold, an increase somewhat larger than 100-fold would apparently be needed to negate vaccination at this dosage level. These two estimates suggest that the effect of vaccination, when measured by relative increases in challenge dose, is slightly greater for small than large challenge doses. Material presented in figure 3 , however, clearly indicates that the effect of vaccination is relatively the same over the whole range of challenge doses used in the present experiment.
There is thus a slight discrepancy between the two ways of estimating the effect of vaccination for different size challenge doses. It would seem that less confidence can be placed on the estimates derived from the data in figure 1 because these estimates depend on the accuracy of preparing serial dilutions. The differences among the 3 challenge suspensions may not have been exactly 100-fold. If they were not, one might quite easily get the differences which appear in figure 1. The effect of vaccination, based on the comparisons shown in figure 3 , would not be influenced by dilution errors: for a given challenge regimen, both vaccinated and unvaccinated groups were inoculated with exactly the same suspension. If one can be reasonably sure that the various subgroups of animals were comparable in other respects, and great care was taken to insure comparability, differences between vaccinated and unvaccinated groups should safely be attributable to the effects of vaccination. The results of the present study, therefore, lead to the conclusion that the effects of vaccination on survival are relatively the same over the whole range of challenge doses used. Figure 3 indicates that vaccination could be estimated to increase survival time about 2.7-fold for females and somewhat less, about 2.1-fold, for males. To quantitate from these estimates the increase in challenge dose that would be needed to negate such increases in survival time, it is necesary to draw on information obtained in earlier studies which deal with the quantitative relation between size of challenge and survival (19) . These studies showed that an inverse linear relation exists between the logarithm of the number of bacilli contained in the challenge dose and the logarithm of survival time in days, a relation similar to that reported to exist for other laboratory animals as well as guinea pigs (13, 26, 27) . This relation means that at any point over a wide range of challenge doses, a certain fold difference in dose would result in a constant proportional difference in survival time. Although the details will not be given here, data published in the earlier paper can be used to translate the relative differences in survival time (2.7-fold for females and 2.1-fold for males) into relative differences in number of bacilli in the challenge. Thus it can be estimated that vaccination is equivalent, for females, to a little more than a 1,000-fold increase and, for males, to somewhat less than a 1,000-fold increase in the number of bacilli in the challenge.
Prom the results of the analysis given in this paper it appears that the effect of vaccination on the progression of a virulent infection can be equated to a certain difference in number of bacilli in the infecting dose. This result suggests that factors determining the course of tuberculosis, that is, host defense, and the size of the bacillary population with which the host must cope would become equal at some point in time probably soon after challenge, provided vaccinated hosts (in this case, guinea pigs) are infected with about 1,000 times as many bacilli as the unvaccinated. For this to occur it would seem necessary to visualize that for some time after challenge, a more rapid multiplication of bacilli occurs in the bodies of the unvaccinated than in the bodies of vaccinated animals. Moreover, it would be necessary to assume that a vaccination preceding a virulent infection will not reduce the host defenses that an animal eventually is able to put up against a virulent infection.
Extensive studies, based on histologic examinations of body tissues and bacterial counts of bacilli in the organs of infected animals, have repeatedly shown that bacilli injected into unvaccinated animals multiply very rapidly (log phase). Within a short time, however, the rate of multiplication is markedly reduced (28) (29) (30) . The initial rapid increase is regarded as due to the absence of resistance and the sudden reduction as due to resistance acquired in response to the virulent infection. In the vaccinated animals, the rate of increase in the size of bacillary population is much slower from the start, which is interpreted as due to resistance induced by vaccination. It would seem, therefore, that about 10 more multiplications, leading to about a 1,000-fold increase in the bacillary population, could well occur in the unvaccinated as compared to the vaccinated animals during the brief period of time it takes the unvaccinated to acquire resistance.
Apparently, both the degree and the speed with which resistance is acquired (in unvaccinated animals from the virulent infection and in the vaccinated both from vaccination and the virulent infection) depend primarily on host characteristics, and are not to any appreciable extent dependent on size of the infecting dose (19) . Therefore, because animals were allocated to the various experimental groups in such a way as to ensure maximum comparability with regard to host-factors before vaccination, it would seem that the groups (both the unvaceinated and the vaccinated) would become equal with regard to host defense against tuberculous infection soon after challenge.
Thus it seems possible to visualize a rather simple mechanism which can account, with no apparent inconsistencies, for the relation observed between size of challenge dose and progression of infection in both vaccinated and unvaccinated animals. For an individual animal, whether vaccinated or not, the speed with which a tuberculous infection will progress would seem to depend simply on the degree of resistance that the animal is able to establish and the number of bacilli with which it must cope at the time resistance is fully developed. According to this view, the effects of vaccination would depend solely on the fact that for a short period of time after challenge, the number of bacilli in unvaccinated animals increases approximately 1,000 times more than it would, had the animals been vaccinated before challenge.
SUMMABT
Survival time, the extent of tuberculous pathology at time of death, and the changes in body weight were investigated in groups of BCG vaccinated and unvaccinated guinea pigs infected with varying numbers of virulent human tubercle bacilli.
Results of the experiment indicated that vaccination had little, if any, effect on the chances that an animal would become infected by a certain number of virulent tubercle bacilli. Moreover, vaccination has no effect, regardless of the size of the challenge, on the final outcome of the infection, eventual death from tuberculosis. The total effect of vaccination on experimental tuberculous infection apparently consists of the influence vaccination has on the speed with which the infection progresses. This effect was found to be the same over the range of challenge doses used, when measured by relative increases in survival times of the vaccinated as compared to unvaccinated animals infected with the same size challenge dose. Moreover, the results indicated that progression of the infection (as measured by survival time, tuberculosis pathology and body weight) can be equalized in vaccinated and unvaccinated animals by inoculating vaccinated ftnimnlq with a larger number of virulent bacilli than given to a comparable group of unvaccinated.
The increase in challenge dose needed to negate the effects of vaccination was estimated to be about 1,000-fold. It is believed that this larger dose will compensate, in vaccinated animals, for the relatively faster increase in the bacillary population that will occur in unvaccinated animals. The larger dose thus neutralizes the only significant factor which determines the progression of the infection in groups of animals with comparable host-characteristics, that is, the size of the bacillary population in the ftnimalq at the time their defenses against the infection are fully developed.
Thus it is concluded that the total effect of BCG vaccination in experimental tuberculosis is related to a partial or complete prevention of the initial high rate of bacillary multiplication in nonimmunized animals before they have acquired resistance.
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